This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

D-Day Arrives for Obamacare - Echoes of Stalinism

Editor's note: Updated from 6 a.m. New throughout.

NEW YORK (TheStreet) -- D-day arrived for ObamaCare Saturday, and began with an 11 hour shutdown of HealthCare.gov -- the problem-plagued Web site intended to provide easy access to affordable insurance for millions of Americans.

The contraption is functioning better but is still terribly inadequate. It can only handle 50,000 users at a time, well short of the volume needed to assist the millions of Americans who must purchase health insurance by year-end or face fines.

Those eligible for subsidies must use the system, but often the system can't verify eligibility for aid. Many are in limbo-applications already initiated are stalled, lost or otherwise can't be completed.

Healthcare.gov software to get insurance companies paid subsidies is not functioning effectively, and the small business site that was to offer group coverage has been postponed one year.

Eventually, Jeff Zients, the Web site's repair czar, will have this monster fulfilling all its functions, but likely it will be a balky, frustrating Web site, much like other federal Web sites or those run by private firms enjoying monopoly power.

Health insurance will be right up there with dealing with tax filing. Bureaucrats will have easy access to sensitive personal data, which Obama Administration political moles can use to target, harass and sometimes destroy critics, and simply occupy millions of hours of citizens' time that could be used more productively.

Welcome to statism: The ants of capitalism herded into a bureaucratic hell to serve the masters of a grander design. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs